Stock Events

Stock Events

Antigenics (CO)

$0.000010

0

+$0.00+0%Wednesday 20:00

Statistics

Day High

-

Day Low

-

52W High

0.00001

52W Low

0.00001

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Moderna Inc. focuses on mRNA-based therapies, directly competing in the innovative vaccine and therapeutic segment similar to Antigenics.

BioNTech SE develops and commercializes immunotherapies, a direct competitor in the field of personalized cancer vaccines and infectious disease vaccines.

Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing in the same vaccine technology space as Antigenics.

Adaptive Biotechnologies

Adaptive Biotechnologies Corp. works on immune-driven medicine, including the use of sequencing and bioinformatics to develop immunotherapies.

CRISPR Therapeutics

CRISPR Therapeutics AG specializes in gene editing technology, which is pivotal for developing next-generation therapies in areas overlapping with Antigenics' interests.

Novartis AG, through its advanced therapy platforms, competes in developing novel treatments in areas such as cancer, which may overlap with Antigenics' therapeutic vaccines.

Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that develops drugs, including for oncology and infectious diseases, competing with Antigenics' research areas.

Amgen Inc. is a biotech giant that develops innovative human therapeutics, including in oncology and immunology, areas relevant to Antigenics.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is known for its monoclonal antibodies and other biopharmaceuticals, competing in the immunotherapy space.

Pfizer Inc. develops and manufactures healthcare products, including vaccines and biopharmaceuticals for diseases that Antigenics also targets.

About

Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.

Show More

CEO

Country

United States

ISIN

US0370311013

Listings

0 Comments

Share your thoughts

FAQs

What is Antigenics (CO) stock price today?▼

The current price of ATGC is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Antigenics (CO) stock price performance more closely on the chart.

What is Antigenics (CO) stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Antigenics (CO) stocks are traded under the ticker ATGC.

In which sector is Antigenics (CO) located?▼

Antigenics (CO) operates in the Other sector.

When did Antigenics (CO) complete a stock split?▼

Antigenics (CO) has not had any recent stock splits.